Altre lingue Kabra Drugs Limited

Azioni

KABRADG

INE323K01017

Mercato chiuso - Bombay S.E. Altri mercati azionari 12:00:58 08/07/2024			Variaz. 5gg	Var. 1 gen.
8,3 ^INR	+4,93%		0,00%	+53,99%

30/05	Kabra Drugs Limited riporta i risultati degli utili per il quarto trimestre e l'intero anno terminato il 31 marzo 2024	CI
14/02	Kabra Drugs Limited riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Kabra Drugs Limited Announces Change of Registered Office Address	12/07
Kabra Drugs Limited announced that it has received INR 56.905 million in funding	05/07
Kabra Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	30/05
Kabra Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02
Kabra Drugs Limited announced that it expects to receive INR 56.905 million in funding	23/01
Kabra Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	13/11
Kabra Drugs Limited Approves to Shift Registered Office	30/09/23
Kabra Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/08/23
Kabra Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	08/06/23
Kabra Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/02/23
Kabra Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/11/22
Kabra Drugs Limited Announces Resignation of Muralidharan R as Director	02/11/22
Kabra Drugs Limited Announces Board Appointments	30/09/22
Kabra Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	13/08/22
Kabra Drugs Limited Announces Executive Changes	07/07/22
Kabra Drugs Limited Announces Appointment of K.N Anand as Additional Director (Independent Director)	09/06/22
Kabra Drugs Limited Announces Resignation of Churchil Durai M Jebastine as Director	30/05/22
Kabra Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	30/05/22
Kabra Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2022	30/05/22
Kabra Drugs Limited Announces Resignation of Pritam Paul as Secretary and Compliance Officer	18/04/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Kabra Drugs Limited

Azioni

KABRADG

INE323K01017

Altre lingue

Filtri